Publications by authors named "Enrico G Italiano"
Background: In the last years, transcatheter aortic valve implantation (TAVI) indication has expanded to younger and lower risk patients. Consequently, interest in mid and long-term follow up and in the role of life expectancy, as a key factor for selecting the most tailored treatment, has grown. The aim of this retrospective study is to compare the 4-year survival of patients who underwent aortic valve replacement (AVR) .
View Article and Find Full Text PDFObjectives: This study aimed to compare gender-related differences in short- and long-term outcomes after transcatheter aortic valve implantation.
Methods: Patients who underwent transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) from September 2017 to December 2022 were enrolled. The primary endpoint was 5-year all-cause mortality.
The current use of intracorporeal left ventricular assist devices in children is still limited by small body dimensions. Many children weighing of less than 30 kg requiring durable mechanical circulatory support are implanted with the Berlin Heart EXCOR, a paracorporeal device. We present the case of a girl aged 10 years with a body surface area of 1.
View Article and Find Full Text PDFBackground: Mechanical cardiac support is currently an effective strategy to reduce morbidity and mortality in pediatric patients. However, solid evidence regarding the feasibility of intracorporeal devices in children still needs to be provided. We report our 10-year experience with intracorporeal left ventricular assist devices (LVAD) in children.
View Article and Find Full Text PDFArticle Synopsis
- * A meta-analysis of 10 studies found no significant difference in perioperative mortality between JWs and non-JWs, despite 86% of non-JWs receiving transfusions.
- * JWs experienced less blood loss and had higher preoperative and postoperative hemoglobin levels, supporting the safety and equivalence of bloodless surgery outcomes; however, more research is needed to understand the long-term effects of reducing transfusions.
The use of left ventricular assist devices (LVADs) is intended to treat patients with end-stage heart failure. Owing to technological advances, these devices are becoming more durable. However, LVADs may need to be exchanged when complications arise and heart transplantation is not possible.
View Article and Find Full Text PDF